| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Jazz Pharmaceuticals plc | 6,363,748 | 10.1% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | Jazz Pharmaceuticals plc | 7,055,747 | 11.2% | EDGAR |
| SC 13G/A | 2023-09-11 | VANGUARD GROUP INC | Jazz Pharmaceuticals plc | 6,479,474 | 10.3% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Jazz Pharmaceuticals plc | 6,050,625 | 9.6% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | Jazz Pharmaceuticals plc | 6,652,382 | 10.6% | EDGAR |
| SC 13G | 2023-01-20 | BlackRock Inc. | Jazz Pharmaceuticals plc | 6,652,382 | 10.6% | EDGAR |
| SC 13G/A | 2023-01-05 | JPMORGAN CHASE & CO | Jazz Pharmaceuticals plc | 2,924,604 | 4.6% | EDGAR |
| SC 13G/A | 2022-02-10 | RENAISSANCE TECHNOLOGIES LLC | Jazz Pharmaceuticals plc | 1,700,509 | 2.8% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Jazz Pharmaceuticals plc | 5,544,701 | 9.0% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Jazz Pharmaceuticals plc | 1,702,656 | 2.8% | EDGAR |
| SC 13G/A | 2022-01-28 | BlackRock Inc. | Jazz Pharmaceuticals plc | 6,450,368 | 10.5% | EDGAR |
| SC 13G | 2022-01-24 | JPMORGAN CHASE & CO | Jazz Pharmaceuticals plc | 3,248,156 | 5.2% | EDGAR |
| SC 13G/A | 2021-02-11 | RENAISSANCE TECHNOLOGIES LLC | Jazz Pharmaceuticals plc | 3,099,050 | 5.6% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | Jazz Pharmaceuticals plc | 4,877,893 | 8.8% | EDGAR |
| SC 13G | 2021-02-08 | FMR LLC | Jazz Pharmaceuticals plc | 2,927,121 | 5.3% | EDGAR |
| SC 13G/A | 2021-02-05 | BlackRock Inc. | Jazz Pharmaceuticals plc | 6,395,173 | 11.5% | EDGAR |
| SC 13G/A | 2020-10-09 | BlackRock Inc. | Jazz Pharmaceuticals plc | 6,095,185 | 11.0% | EDGAR |
| SC 13G/A | 2020-02-14 | PUTNAM INVESTMENTS LLC | Jazz Pharmaceuticals plc | 761,612 | 1.3% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | Jazz Pharmaceuticals plc | 5,041,218 | 8.9% | EDGAR |
| SC 13G | 2020-02-12 | RENAISSANCE TECHNOLOGIES LLC | Jazz Pharmaceuticals plc | 3,549,371 | 6.3% | EDGAR |